Surgery Partners, Inc. (SGRY) stock is down 13.71% in the pre-market session on Tuesday, June 17, 2025, trading at $19.99 compared to the previous day’s close of $23.17.
The sharp decline follows the company’s release of its financial forecast for fiscal year 2025 ahead of market open.
Surgery Partners reaffirmed revenue between $3.3 billion and $3.45 billion for 2025, closely aligning with Wall Street’s estimate of $3.38 billion.